Browsed by
Tag: Senate

Science policy weekly roundup: April 19, 2019 ?>

Science policy weekly roundup: April 19, 2019

House cancels vote on bill to raise federal spending caps Leadership from the U.S. House canceled a vote on a bill April 9 that would raise the federal spending caps for fiscal year 2020. The cancellation comes amid disagreement between moderate Democrats, who say the increase is too high, and progressive Democrats, who say it is too low. House leaders are now negotiating with their U.S. Senate counterparts for a bipartisan solution to increase federal spending caps. Read more here….

Read More Read More

Legislative Update – Appropriations and the Senate innovation agenda ?>

Legislative Update – Appropriations and the Senate innovation agenda

As discussed last week, the appropriations process continues to progress behind closed doors. However, some details are emerging. All appropriations subcommittees have received their 302(b) allocations, and those allocations have been described to me by congressional staff as “fair.” The allocation for the Labor, Health and Human Services appropriations subcommittee, which funds the National Institutes of Health, is said to be “generous.” The original allocation for L-HHS had been below the fiscal year 2015 level, but it seems the Bipartisan…

Read More Read More

Where’ve We Been? Meeting with Appropriations Staff! ?>

Where’ve We Been? Meeting with Appropriations Staff!

Yesterday, Ben visited with appropriations staff to discuss the where Congress is in the budgeting process for FY16.  It turns out, the Appropriations Committee and their subcommittees have been working diligently to negotiate updated appropriations bills with the new funds made available thanks to the Bipartisan Budget Agreement of 2015.  Subcommittees have already been provided there 302(b) allocations, and rumor has it there is potential for research agencies like the National Institutes of Health and National Science Foundation are poised…

Read More Read More

21st Century Cures Heads to the Senate ?>

21st Century Cures Heads to the Senate

With bipartisan support, the 21st Century Cures Act was passed on the floor of the House of Representatives by a vote of 344-77 after overcoming a variety of political challenges.  This bill provides $1.86 billion per year in mandatory funding for the National Institutes of Health from fiscal 2016 to FY20 through an innovation fund and seeks to streamline the approval process for drugs from the Food and Drug Administration.